- $8.62bn
- $8.40bn
- $2.26bn
- 99
- 21
- 56
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,939 | 2,080 | 2,139 | 2,135 | 2,264 |
Cost of Revenue | |||||
Gross Profit | 617 | 701 | 770 | 765 | 799 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,681 | 1,690 | 1,796 | 1,791 | 1,924 |
Operating Profit | 257 | 390 | 343 | 343 | 341 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 262 | 396 | 350 | 330 | 350 |
Provision for Income Taxes | |||||
Net Income After Taxes | 220 | 319 | 269 | 250 | 273 |
Net Income Before Extraordinary Items | |||||
Net Income | 220 | 319 | 269 | 250 | 273 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 220 | 319 | 269 | 250 | 273 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 14 | 18.2 | 18.3 | 17.2 | 18.6 |
Dividends per Share |